ErinAnnBohulaMD
Cardiology • Boston, MAAdult Congenital Heart Disease
Cardiologist, Brigham and Women's Hospital; Investigator, TIMI Study Group
Dr. Bohula is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
Boston, MA 02115Phone+1 617-732-6660
Education & Training
Brigham and Women's HospitalFellowship, Cardiovascular Disease, 2010 - 2013- Brigham and Women's HospitalResidency, Internal Medicine, 2007 - 2010
Harvard Medical SchoolClass of 2007
Certifications & Licensure
MA State Medical License 2009 - 2027
American Board of Internal Medicine Cardiovascular Disease- American Board of Internal Medicine Critical Care Medicine
Clinical Trials
- IMPROVE-IT: Examining Outcomes in Subjects With Acute Coronary Syndrome: Vytorin (Ezetimibe/Simvastatin) vs Simvastatin (P04103) Start of enrollment: 2005 Oct 17
- Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events Start of enrollment: 2013 Apr 25
Publications & Presentations
PubMed
- Patterns of Prophylactic Anticoagulation Among Patients Hospitalized for COVID-19: An Analysis of the American Heart Association COVID-19 Cardiovascular Disease Registry.Mathew S Lopes, Hsin-Fang Li, Reed J D Sorensen, Sandeep Das, Steven M Bradley
Journal of the American Heart Association. 2025-03-04 - Differences Between Ischemic and Nonischemic Cardiomyopathy in Heart Failure Related Cardiogenic Shock.Jason Feinman, Matthew I Tomey, Michael G Palazzolo, Miguel Martillo, Maria Ronquillo
Journal of Cardiac Failure. 2025-02-26 - Epidemiology and Prognostic Significance of Acute Non-Cardiac Organ Dysfunction across Cardiogenic Shock Subtypes: Varshney et al; Non-Cardiac Organ Dysfunction in CS.Anubodh S Varshney, Michael G Palazzolo, Christopher F Barnett, Erin A Bohula, James A Burke
Journal of Cardiac Failure. 2025-02-25
Journal Articles
- Cardiovascular Safety of Lorcaserin in Overweight or Obese PatientsErin A Bohula, Stephen D Wiviott, Benjamin M Scirica, Darren K McGuire, Marc S Sabatine, Marc P Bonaca, Christian T Ruff, Silvio E Inzucchi, The New England Journal of Medicine
- Cardiovascular Safety of Lorcaserin in Overweight or Obese PatientsChristina L. Fanola, Darren K. McGuire, Silvio E. Inzucchi, Erin A. Bohula, The New England Journal of Medicine
Lectures
- Acute Cardiogenic Shock: Progress Paradigms and Problems2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
- Audience ARS Question2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
- CAMELLIA-TIMI 61 Trial2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
- Join now to see all
Press Mentions
COVID-PACT: Full-Dose Anticoagulation Improves Outcomes in Critical COVID-19September 1st, 2022- Episode 75 - Multisystem Inflammatory SyndromeNovember 19th, 2021
- Access to Obesity Medications Boosts Weight Loss in Employer-Based ProgramAugust 4th, 2021
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
